Kathleen Rewers‐Felkins

Author

Also Known As

K. A. Rewers‐Felkins, K. Rewers-Felkins, K.A. Rewers-Felkins, KATHLEEN A. REWERS-FELKINS, Kathleen A Rewers-Felkins, Kathleen A. Rewers-Felkins, Kathleen Rewers-Felkins, Kathleen Rewers‐Felkins

Publications

642

Citations

H-Index

Concepts

All Affiliations

Texas Tech University Texas Tech University Health Sciences Center Harrington Cancer Center Amarillo VA Health Care System Memorial Blood Centers

About

Kathleen Rewers‐Felkins is an author at Texas Tech University specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	217
2	Cell Biology	6	6	106
3	Cellular Physiology	2	2	24
4	Public Health	1	1	27
5	Biochemistry	1	1	27

Kathleen Rewers‐Felkins

Publications

570

Citations

H-Index

Page 1

	Year	Citations
Transfer of Inhaled Cannabis Into Human Breast Milk Teresa Baker, Palika Datta, Kathleen Rewers‐Felkins, Obstetrics and Gynecology	2018	125
Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate “Natural” and “Inducible” CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer Mark J. Dobrzanski, Kathleen Rewers‐Felkins, Khaliquzzaman Samad, Cancer Immunology Immunotherapy “ Natural ”Cancer ImmunosurveillanceMedicineT-regulatory CellImmunology	2011	48
CD8-Mediated Type 1 Antitumor Responses Selectively Modulate Endogenous Differentiated and Nondifferentiated T Cell Localization, Activation, and Function in Progressive Breast Cancer Mark J. Dobrzanski, Joyce B. Reome, James C. Hylind, The Journal of Immunology	2006	43
Cytotoxic T-lymphocyte Immunotherapy for Ovarian Cancer Stephen E. Wright, Kathleen Rewers‐Felkins, Imelda S. Quinlin, Journal of Immunotherapy Lymphoid NeoplasiaCancer ImmunosurveillanceMedicineImmunologyImmunoediting	2012	36
Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival Mark J. Dobrzanski, Kathleen Rewers‐Felkins, Imelda S. Quinlin, Clinical Immunology Cancer ImmunosurveillanceDifferential LevelsT-regulatory CellImmunologyRegulatory T Cells	2009	36
Transfer of Low Dose Aspirin Into Human Milk Palika Datta, Kathleen Rewers‐Felkins, Raja Reddy Kallem, Journal of Human Lactation	2017	34
Characterization of protective immunity induced against<i>Schistosoma mansoni</i>via DNA priming with the large subunit of calpain (Sm-p80) in the presence of genetic adjuvants Afzal A. Siddiqui, Justin R. Pinkston, Martha L. Quinlin, Parasite	2005	27
Cladribine transfer into human milk: A case report Palika Datta, Andrea I. Ciplea, Kathleen Rewers‐Felkins, Multiple Sclerosis Journal	2020	27
Dimethyl fumarate transfer into human milk Andrea I. Ciplea, Palika Datta, Kathleen Rewers‐Felkins, Therapeutic Advances in Neurological Disorders NutritionDimethyl Fumarate TransferLactationBiochemistryInfant Nutrition	2020	27
Tumor Burden Influences Cytotoxic T Cell Development in Metastatic Breast Cancer Patients—A Phase I/II Study Stephen E. Wright, Kathleen Rewers‐Felkins, Imelda S. Quinlin, Immunological Investigations Tumor ResponseBreast OncologyCancer ImmunosurveillanceMedicineTumor Burden	2009	21

Page 1